Cindy J. Rubin

Obesity in Black Adolescent Girls: A Controlled Clinical Trial of Treatment by Diet, Behavior Modification, and Parental Support

Thomas A. Wadden, Albert J. Stunkard, Linda J. Rich et al. · PEDIATRICS · 1990 · 227 citations

Family Medicine, Weight Management, Black American Women +22

Improvement of Glycemic Control, Triglycerides, and HDL Cholesterol Levels With Muraglitazar, a Dual (α/γ) Peroxisome Proliferator–Activated Receptor Activator, in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy

David M. Kendall, Cindy J. Rubin, Pharis Mohideen et al. · Diabetes Care · 2006 · 114 citations

Metformin Monotherapy, Pharmacotherapy, Mg Muraglitazar +18

Muraglitazar, a dual (α/γ) PPAR activator: A randomized, double-blind, placebo-controlled, 24-week monotherapy trial in adult patients with type 2 diabetes

John B. Buse, Cindy J. Rubin, Robert Frederich et al. · Clinical Therapeutics · 2005 · 98 citations

Diabetes Management, Ppar Activator, Medicine +7

Multicenter, randomized, double-masked, parallel-group assessment of simultaneous glipizide/metformin as second-line pharmacologic treatment for patients with type 2 diabetes mellitus that is inadequately controlled by a sulfonylurea

Barry J. Goldstein, Miranda Pans, Cindy J. Rubin · Clinical Therapeutics · 2003 · 61 citations

Metabolic Syndrome, Diabetes Management, Diabetes +7

Abnormally persistent latent inhibition induced by MK801 is reversed by risperidone and by positive modulators of NMDA receptor function: differential efficacy depending on the stage of the task at which they are administered

Inna Gaisler‐Salomon, L. Diamant, Cindy J. Rubin et al. · Psychopharmacology · 2007 · 34 citations

Nmda Receptor Function, Psychoactive Drug, Psychiatry +10